SCHEMBL4255146

SCHEMBL4255146

CCC(=Cc1ccc(C(=C2CC(C)(C)CC(C)(C)C2)c2ccc(O)c(Cl)c2)cc1)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
EPHX2 P34913 1/20 0.34
PPARG P37231 1/20 0.34
TBXAS1 P24557 2/20 0.34
RARB P10826 4/20 0.33
RARG P13631 4/20 0.33
RARA P10276 3/20 0.33
RXRA P19793 2/20 0.33
ESR1 P03372 3/20 0.33
ESR2 Q92731 1/20 0.33
OPRM1 P35372 2/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
P4HB P07237 1/20 0.32
PTGS1 P23219 1/20 0.32
ADCYAP1R1 P41586 1/20 0.31
GRIK1 P39086 1/20 0.31
BACE1 P56817 1/20 0.31
RXRB P28702 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4252411 0.89 HSP90AA1 (0.36) HSP90AA1HSP90AB1EPHX2PPARGTBXAS1
SCHEMBL4264978 0.88 SNCA (0.37) EPHX2PPARGTBXAS1RARBRARG
SCHEMBL4259406 0.86 ESR1 (0.43) EPHX2PPARGTBXAS1ESR1ESR2
SCHEMBL4257163 0.84 ESR1 (0.39) HSP90AA1HSP90AB1EPHX2PPARGTBXAS1
SCHEMBL4255132 0.84 ESR1 (0.39) HSP90AA1HSP90AB1EPHX2PPARGTBXAS1
SCHEMBL4255138 0.82 HSP90AA1 (0.39) HSP90AA1HSP90AB1RARBRXRAESR1
SCHEMBL3468537 0.81 PTPN11 (0.42) RXRAESR1ESR2BACE1
SCHEMBL3468534 0.81 PTPN11 (0.42) RXRAESR1ESR2BACE1
SCHEMBL4255135 0.78 TTR (0.49) ESR1BACE1
SCHEMBL4255141 0.78 TTR (0.49) ESR1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569601-B2 Cycloalkylidene compounds as modulators of estrogen receptor SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
US-20070213348-A1 Chemical Compounds BRITTON JONATHAN E 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213348-A1 Chemical Compounds GPER1, ESR2, ESR1 HSP90AA1 2233/4885HSP90AB1 1255/4885EPHX2 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.